AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20418724
Drug: Patient-selected treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-selected treatment partner-assisted therapy (TPA)
Trial: 18752863
Drug: Interferon-ribavirin therapy
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Interferon-ribavirin therapy
Trial: 2175354
Drug: canrenoate potassium
RxNorm normalized name: canrenoate potassium
DrugBank: Canrenoic acid (DB09015)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: canrenoate potassium at 200 mg/day
Trial: 26395129
Drug: Purified Shilajit
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Shilajit (250 mg twice a day for 90 days)
Trial: 8964276
Drug: Lamotrigine 100
RxNorm normalized name: lamotrigine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine 100 mg (LTG 100)
Trial: 22068817
Drug: Chemotherapy regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy regimen according to ATP‐CRA (Group B)
Trial: 31332820
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg twice daily for 3 days
Trial: 9768932
Drug: Low-dose aprotinin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose aprotinin (group A; n = 14)
Trial: 12071235
Drug: Iontophoretic application
RxNorm normalized name: Sumatriptan Iontophoretic Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iontophoretic application of lidocaine (60 mg)
Trial: 101223
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg thrice daily
Trial: 804952
Drug: All active
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All active treatments (Tolamolol, Propranolol, Practolol)
Trial: 32949
Drug: Dummy preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dummy preparations (control)
Trial: 24308188
Drug: ZHUANG medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZHUANG medicine mediated thread moxibustion (ZMMTM) combined with Sulfasalazine (SASP)
Trial: 26120851
Drug: Interactive injection
RxNorm normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interactive injection risk intervention
Trial: 7509509
Drug: 5,000 units
RxNorm normalized name: Lapase, 1200 units-15,000 units-15,000 units oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5,000 units standard heparin given twice-daily
Trial: 3207328
Drug: Size 12
RxNorm normalized name: GRISEOFULVIN,MICROSIZE 125MG CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Size 12 G latex rubber balloon catheter
Trial: 12395330
Drug: VPA-985 300
RxNorm normalized name: VPA
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VPA-985 300 mg
Trial: 10091762
Drug: Dose-dense arm
RxNorm normalized name: ARM-210
DrugBank: ARM-210 (DB16944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-dense arm
Trial: 2247670
Drug: Intratracheal lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intratracheal lignocaine (4 ml, 4%)
Trial: 16202481
Drug: Scopolamine 0.3
RxNorm normalized name: scopolamine 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine 0.3 mg
Trial: 3925478
Drug: Scopolamine 0.6
RxNorm normalized name: scopolamine 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scopolamine 0.6 mg
Trial: 19433666
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba 120 mg twice a day
Trial: 10767728
Drug: Mianserin 30-60
RxNorm normalized name: mianserin 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mianserin 30-60 mg/day
Trial: 1552056
Drug: Tretinoin emollient
RxNorm normalized name: Tretinoin Emollient Topical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tretinoin emollient cream 0.05%
Trial: 21875635
Drug: Non-adjuvanted whole
RxNorm normalized name: HYACINTHOIDES NON-SCRIPTA WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjuvanted whole virion H1N1 vaccine
Trial: 11109306
Drug: Cocarboxylase (CC)
RxNorm normalized name: Cocarboxylase
DrugBank: Cocarboxylase (DB01987)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocarboxylase (CC) administration, 5 mg/kg body weight, 3 times a week for 12 weeks.
Trial: 26708675
Drug: Cooling to
RxNorm normalized name: Castiva Cooling Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooling to a rectal temperature of 33·5°C for 72 h (standard treatment).
Trial: 26056407
Drug: Patient medication
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient medication monograph only (PMMO)
Trial: 10378820
Drug: Diltiazem XR
RxNorm normalized name: diltiazem Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem XR 200 mg
Trial: 10378820
Drug: Diltiazem XR
RxNorm normalized name: diltiazem Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem XR 300 mg
Trial: 24763156
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy intervention (6-week program, twice weekly group classes and once weekly home practice)
Trial: 20635633
Drug: Antihelminthic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihelminthic therapy (400 mg albendazole, two doses)
Trial: 23735180
Drug: Test sirolimus
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Test sirolimus tablets
Trial: 17582403
Drug: Headfirst sperm
RxNorm normalized name: herring sperm DNA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Headfirst sperm injection
Trial: 11874944
Drug: Troglitazone 200
RxNorm normalized name: troglitazone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Troglitazone 200 mg once daily
Trial: 29174079
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no surfactant administered, maintained on CPAP)
Trial: 22142813
Drug: Griffonia Simplicifolia
RxNorm normalized name: Griffonia Simplicifolia Seed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Griffonia Simplicifolia extract (5-hydroxytryptophan) administered via oral spray for 4 weeks
Trial: 8074597
Drug: Pamidronate disodium,
RxNorm normalized name: Pamidronate Disodium, 3 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate disodium, 60 mg, over 24 hours
Trial: 9848833
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic (one drop before lens insertion at fitting and dispensing visits)
Trial: 17700049
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nefazodone and IPT
Trial: 11310450
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for secondary NHL
Trial: 7506181
Drug: paracetamol
RxNorm normalized name: Paracetamol
DrugBank: Acetaminophen (DB00316)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: paracetamol
Trial: 16415311
Drug: Oxybutynin 5
RxNorm normalized name: oxyBUTYnin 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin 5 mg
Trial: 16939998
Drug: Theophylline treatment
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline treatment in non-obese participants
Trial: 22136660
Drug: Lactobacillus rhamnosus
RxNorm normalized name: Lactobacillus Rhamnosus
DrugBank: Lacticaseibacillus rhamnosus (DB19282)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus rhamnosus GG (LGG) administered to mothers during late pregnancy
Trial: 2044394
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba extract (40 mg, 3 times daily)
Trial: 12011124
Drug: ACVBP chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACVBP chemotherapy (doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone)
Trial: 4047707
Drug: Ibuprofen, 400
RxNorm normalized name: Ibuprofen, 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 400 mg
Trial: 8459971
Drug: Sodium etidronate
RxNorm normalized name: Sodium etidronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium etidronate 400 mg/day for 14 days followed by calcium carbonate 500 mg/day for 42 days plus norethindrone 2.5 mg/day
Trial: 19835582
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of GILP
Trial: 19835582
Drug: 20 g
RxNorm normalized name: PEG-20 glyceryl oleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 g of GILP
Trial: 16462287
Drug: 3-dose schedule
RxNorm normalized name: hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3-dose schedule initiated in the neonatal period
Trial: 211983
Drug: Fluphenazine enanthate
RxNorm normalized name: Fluphenazine Enanthate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine enanthate high-dose (1 ml) with family therapy
Trial: 8241697
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (2 mg/kg per day)
Trial: 17357181
Drug: 12-week controlled
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week controlled antidepressant monotherapy trial
Trial: 15735613
Drug: Immediate-release metoprolol
RxNorm normalized name: metoprolol Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release metoprolol
Trial: 26755098
Drug: Simultaneous intake
RxNorm normalized name: Fc fusion protein of a human inducible T cell costimulator ligand variant immunoglobulin domain designed to inhibit simultaneously the CD28 and ICOS inflammation pathways
DrugBank: Acazicolcept (DB18410)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simultaneous intake of grass and ragweed SLIT tablets
Trial: 23214314
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education management and lifestyle intervention (on the basis of group B's therapy)
Trial: 16885042
Drug: Thalidomide 400
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide 400 mg/d
Trial: 12865592
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no HRT or other treatments)
Trial: 12201921
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (1 mg kg(‐1), IM)
Trial: 3908132
Drug: Nifedipine 60
RxNorm normalized name: nifedipine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 60 mg/day for 3 weeks
Trial: 27403058
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution used for irrigation
Trial: 12933390
Drug: Ropivacaine 0.2%
RxNorm normalized name: ROPivacaine 0.2% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.2% plus clonidine 1 micro g/mL
Trial: 10739849
Drug: Elevated maternal
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated maternal total homocysteine concentrations (fasting >18.3 micromol/l and/or 6 h after methionine load >61.5 micromol/l)
Trial: 27102981
Drug: All routes
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All routes of administration
Trial: 27305830
Drug: Medication continuation
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication continuation (quetiapine 400 mg/day)
Trial: 27305830
Drug: Medication discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication discontinuation (placebo)
Trial: 2337035
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg twice daily
Trial: 23904009
Drug: Modular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modular treatment (N=15)
Trial: 29274727
Drug: Guideline antiplatelet
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline antiplatelet therapy (clopidogrel alone or combined aspirin and dipyridamole)
Trial: 26079743
Drug: Guideline antiplatelet
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline antiplatelet therapy
Trial: 1290434
Drug: Danazol 50
RxNorm normalized name: danazol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Danazol 50 mg and 100 mg maintenance doses
Trial: 2921588
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate 3.0 mg/70 kg
Trial: 2921588
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate 6.0 mg/70 kg
Trial: 2921588
Drug: Atropine sulfate
RxNorm normalized name: Atropine Sulfate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulfate (all doses)
Trial: 3498395
Drug: Propofol injection
RxNorm normalized name: propofol Injection
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol injection at 15 seconds
Trial: 3498395
Drug: Propofol injection
RxNorm normalized name: propofol Injection
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol injection at 45 seconds
Trial: 1856249
Drug: Ferric maltol
RxNorm normalized name: Ferric Maltol
DrugBank: Ferric maltol (DB15598)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ferric maltol (60 mg elemental iron as tablets)
Trial: 15901232
Drug: Resilient Peer
RxNorm normalized name: dimethicone
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Resilient Peer Treatment (RPT)
Trial: 12928941
Drug: Anakinra (Kineret®)
RxNorm normalized name: anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Anakinra (Kineret®) as monotherapy or in combination with methotrexate
Trial: 19478715
Drug: Intratympanic injection
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic injection of prednisolone
Trial: 19478715
Drug: Intratympanic injection
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic injection of dexamethasone
Trial: 21898340
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate (CS) 800 mg once daily for 6 months
Trial: 3189700
Drug: Intravenous crystalline
RxNorm normalized name: Mesembryanthemum crystallinum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous crystalline penicillin for 5 days
Trial: 17005801
Drug: Daptomycin 10
RxNorm normalized name: daptomycin 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daptomycin 10 mg/kg once daily for 14 days
Trial: 17005801
Drug: Daptomycin 12
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin 12 mg/kg once daily for 14 days
Trial: 17005801
Drug: Daptomycin 6
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin 6 or 8 mg/kg once daily for 4 days
Trial: 27480628
Drug: Low-dose chest
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chest computed tomography (LDCT)
Trial: 10877193
Drug: Acetyl-L-carnitine (ALC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (ALC) infusion
Trial: 19767791
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg diazepam (HIGH)
Trial: 17351746
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg Afimoxifene gel
Trial: 25185574
Drug: 60 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 μg alum‐adjuvanted OspA antigen
Trial: 7870932
Drug: Cocaine administration
RxNorm normalized name: Cocaine
DrugBank: Cocaine (DB00907)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cocaine administration
Trial: 17118828
Drug: Topical cooling
RxNorm normalized name: Castiva Cooling Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cooling with ice‐slush
Trial: 15302008
Drug: Tezosentan 25
RxNorm normalized name: TEZOSENTAN
DrugBank: Tezosentan (DB06558)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tezosentan 25 mg/h
Trial: 2178298
Drug: AVP antagonist
RxNorm normalized name: Interleukin-1 receptor antagonist anakinra
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: AVP antagonist [d(CH2)5 Tyr(Me)AVP] 10 micrograms/kg
Trial: 7846463
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg melatonin administered at 1900 hours
Trial: 7846463
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg melatonin administered at 2100 hours
Trial: 2113590
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of long-term and short-term instillation protocols
Trial: 19447387
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) treatment
Trial: 2486583
Drug: Supplemental boluses
RxNorm normalized name: phenylbutazone
DrugBank: Phenylbutazone (DB00812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Supplemental boluses of 4 ml of 0.5% bupivacaine
Trial: 24648506
Drug: Amoxicillin twice
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin twice daily (50 mg/kg/day)
Trial: 18803866
Drug: B-vitamin supplementation
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: B-vitamin supplementation (folic acid 2 mg, vitamin B6 25 mg, vitamin B12 0.5 mg)
Trial: 11369828
Drug: Beta-blocker (atenolol)
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker (atenolol)
Trial: 11369828
Drug: Non-dihydropyridine calcium
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-dihydropyridine calcium channel blocker (verapamil)
Trial: 9416381
Drug: Bismuth subsalicylate
RxNorm normalized name: Bismuth Subsalicylate
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bismuth subsalicylate formulation without Veegum
Trial: 22065400
Drug: bosutinib 500
RxNorm normalized name: bosutinib 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bosutinib 500 mg plus ketoconazole (supratherapeutic)
Trial: 16020405
Drug: Valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan 80 mg/day (increased to 160 mg as tolerated)
Trial: 8686411
Drug: High potency
RxNorm normalized name: High Potency B+C
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High potency pancreatin (9 g, 3 g x 3 times) for approximately 1 month
Trial: 22941193
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (NaHCO(3)) 0.3 g kg(‐1)
Trial: 11518628
Drug: Topiramate low
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate low dosage (100 mg daily)
Trial: 9443517
Drug: High oral
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High oral dose of D-amphetamine
Trial: 9443517
Drug: Low oral
RxNorm normalized name: Milkflow oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low oral dose of D-amphetamine
Trial: 2196193
Drug: Glipizide 15
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide 15 mg daily